SCHEMBL29439624

SCHEMBL29439624

FC(F)CNc1ncnc2ccc(Cl)nc12

nearest known ligand 0.50

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 6/20 0.50
EGFR P00533 2/20 0.47
MKNK2 Q9HBH9 8/20 0.38
PIK3CD O00329 3/20 0.35
PIK3R2 O00459 3/20 0.35
PIK3CG P48736 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22715352 1.00 MAP4K4 (0.50) MAP4K4EGFRMKNK2PIK3CDPIK3R2
SCHEMBL29439758 0.80 MAP4K4 (0.54) MAP4K4EGFRMKNK2PIK3CDPIK3R2
SCHEMBL22715501 0.80 MAP4K4 (0.54) MAP4K4EGFRMKNK2PIK3CDPIK3R2
SCHEMBL29439619 0.77 EGFR (0.47) MAP4K4EGFRMKNK2PIK3CDPIK3R2
SCHEMBL22715219 0.77 EGFR (0.47) MAP4K4EGFRMKNK2PIK3CDPIK3R2
SCHEMBL2621718 0.74 EGFR (0.54) MAP4K4EGFRMKNK2PIK3CDPIK3R2
SCHEMBL29439793 0.74 EGFR (0.54) MAP4K4EGFRMKNK2PIK3CDPIK3R2
SCHEMBL30942376 0.70 MAT2A (0.35) MAP4K4
SCHEMBL12277000 0.70 MEN1 (0.52) MAP4K4EGFRMEN1KMT2A
SCHEMBL16767066 0.70 EGFR (0.59) EGFRMKNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118908957-A Small molecule inhibitors of NF- κB induced kinase 詹森药业有限公司 2024-11-08 CN disclosed
CN-114222737-B Small molecule inhibitors of NF- κB induced kinase 詹森药业有限公司 2024-07-26 CN disclosed
EP-3976597-A1 SMALL MOLECULE INHIBITORS OF NF-KB INDUCING KINASE Janssen Pharmaceutica NV (BE) 2022-04-06 EP disclosed
CN-114222737-A Small molecule inhibitor of NF-kB induced kinase 詹森药业有限公司 2022-03-22 CN disclosed